EXHIBIT 1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of Palvella Therapeutics, Inc. and that this Agreement be included as an Exhibit to such joint filing. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this [__] day of December, 2024.

 

 

 

       
  Name: Wesley H. Kaupinen  
       
       
  Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019  
       
       
  By:    
    Name: Christine L. Kaupinen  
    Title: Trustee  
       
       
       
  Name: Christine L. Kaupinen  
       
       
  Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019  
       
       
  By:    
    Name: Michael Christopher  
    Title: Trustee  
       
       
       
    Name: Michael Christopher  

 

 
Palvella Therapeutics (NASDAQ:PVLA)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025 Click aqui para mais gráficos Palvella Therapeutics.
Palvella Therapeutics (NASDAQ:PVLA)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025 Click aqui para mais gráficos Palvella Therapeutics.